Shares of Peak Pharmaceuticals, Inc. (OTCMKTS:PKPH – Get Free Report) fell 0.6% during trading on Thursday . The company traded as low as $0.9811 and last traded at $0.9943. 10,070 shares were traded during mid-day trading, an increase of 11% from the average session volume of 9,053 shares. The stock had previously closed at $1.00.
Peak Pharmaceuticals Stock Performance
The company’s 50-day moving average is $0.97 and its two-hundred day moving average is $1.24.
About Peak Pharmaceuticals
Peak Pharmaceuticals, Inc manufactures and markets pharmaceutical level products containing phytocannabinoids, an abundant and pharmaceutically active component of industrial hemp for the prevention and alleviation of various conditions and diseases. The company was founded on December 18, 2007 and is headquartered in Scottsdale, AZ.
See Also
- Five stocks we like better than Peak Pharmaceuticals
- Nutanix’s Rally Has a Bigger Story Than Earnings as AMD’s AI Bet Takes Shape
- SEC Probe Puts Wall Street Leverage Risk Back in Focus
- A Bearish-Dollar Options Surge Raises the Stakes for Warsh at Jackson Hole
- Five Below’s Turnaround Is Working—But Has the Stock Run Too Far?
Receive News & Ratings for Peak Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Peak Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
